MCID: CLT003
MIFTS: 63

Colitis

Categories: Gastrointestinal diseases

Aliases & Classifications for Colitis

MalaCards integrated aliases for Colitis:

Name: Colitis 12 72 28 51 41 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0060180
ICD10 32 K52.9
MeSH 41 D003092
NCIt 46 C26723
SNOMED-CT 64 64226004
UMLS 69 C0009319

Summaries for Colitis

Disease Ontology : 12 An inflammatory bowel disease that involves inflammation located in colon.

MalaCards based summary : Colitis is related to microscopic colitis and crohn's colitis. An important gene associated with Colitis is NOD2 (Nucleotide Binding Oligomerization Domain Containing 2), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Azathioprine and Hydrocortisone have been mentioned in the context of this disorder. Affiliated tissues include colon, colon and t cells, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

Wikipedia : 72 Colitis is an inflammation of the colon. Colitis may be acute and self-limited or long-term. It broadly... more...

Related Diseases for Colitis

Diseases related to Colitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 781)
# Related Disease Score Top Affiliating Genes
1 microscopic colitis 34.4 IFNG IL2 TNF
2 crohn's colitis 33.6 CXCL8 IFNG IL1B IL2 NOD2 TNF
3 pouchitis 32.9 CXCL8 IL10 NOD2
4 inflammatory bowel disease 25, autosomal recessive 32.9 IL10 IL10RA IL10RB
5 pyoderma gangrenosum 32.7 CXCL8 NOD2 TNF
6 ulcerative colitis 32.7 ABCB1 ATG16L1 CTNNB1 CXCL8 IFNG IL10
7 gastroenteritis 32.6 CXCL8 IFNG IL10 IL1B TNF
8 irritable bowel syndrome 32.3 IL10 TLR9 TNF
9 ileocolitis 31.8 MYO9B NOD2 TNF
10 crohn's disease 31.5 ABCB1 ATG16L1 IFNG IL10 IL10RA IL10RB
11 pyoderma 31.3 CXCL8 NOD2 TNF
12 ileitis 31.2 IL17A MPO NOD2 TLR9 TNF
13 colorectal cancer 30.9 ABCB1 CTNNB1 CXCL8 IFNG IL10 IL1B
14 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 30.8 IFNG IL10 IL17A
15 cytomegalovirus infection 30.7 CXCL8 IFNG IL10 TNF
16 celiac disease 1 30.7 IFNG IL10 IL2 MYO9B TNF
17 appendicitis 30.4 CXCL8 IL10 IL1B MPO TNF
18 spondylitis 30.3 IL17A IL23R NOD2 TNF
19 hematopoietic stem cell transplantation 30.2 IFNG IL10 IL2 TNF
20 trichuriasis 30.2 CXCL8 IL10 TNF
21 peritonitis 30.2 CXCL8 IFNG IL10 IL1B TNF
22 familial mediterranean fever 30.2 IL1B NOD2 TNF
23 spondyloarthropathy 1 30.2 IL17A NOD2 TNF
24 autoimmune inner ear disease 30.2 MPO TNF
25 inflammatory bowel disease 30.2 ABCB1 ATG16L1 CXCL8 IFNG IL10 IL10RA
26 arthritis 30.1 CXCL8 IFNG IL10 IL17A IL1B NOD2
27 chronic granulomatous disease 30.1 IFNG IL1B MPO TLR9 TNF
28 reactive arthritis 30.0 IFNG IL10 IL17A TNF
29 transverse myelitis 30.0 CXCL8 IL10 IL17A TNF
30 kidney cancer 30.0 CXCL8 IFNG IL2 TNF
31 prostatitis 30.0 CXCL8 IL10 IL1B TNF
32 pyelonephritis 30.0 CXCL8 IL10 IL1B TNF
33 bronchiolitis obliterans 30.0 CXCL8 IFNG IL10 IL17A TNF
34 acquired immunodeficiency syndrome 30.0 IFNG IL10 IL1B IL2 TNF
35 vaginitis 30.0 ABCB1 CXCL8 IL1B
36 brucellosis 30.0 CXCL8 IFNG IL10 IL2 TNF
37 spondyloarthropathy 30.0 IFNG IL10 IL17A IL2 TNF
38 wegener granulomatosis 30.0 CXCL8 IFNG IL10 MPO TNF
39 uveitis 29.9 IFNG IL10 IL17A NOD2 TNF
40 wells syndrome 29.9 CXCL8 IL1B IL2
41 pneumonia 29.9 CXCL8 IL10 IL1B MPO TLR9 TNF
42 pleurisy 29.9 CXCL8 IFNG IL2 MPO TNF
43 erythema multiforme 29.9 IFNG IL2 TNF
44 graft-versus-host disease 29.9 IFNG IL10 IL1B IL2 TNF
45 hidradenitis suppurativa 29.9 IL17A NOD2 TNF
46 hidradenitis 29.9 IL17A NOD2 TNF
47 immune suppression 29.9 IFNG IL10 IL2
48 osteomyelitis 29.9 CXCL8 IFNG IL10 IL1B TNF
49 helicobacter pylori infection 29.9 CXCL8 IFNG IL10 IL1B TNF
50 bronchitis 29.9 CXCL8 MPO TNF

Graphical network of the top 20 diseases related to Colitis:



Diseases related to Colitis

Symptoms & Phenotypes for Colitis

GenomeRNAi Phenotypes related to Colitis according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.88 MYO9B NOD2 TNF CXCL8 IL10 IL17A
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.88 MYO9B NOD2 TNF CXCL8 IL10 IL17A

MGI Mouse Phenotypes related to Colitis:

43 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.36 ABCB1 ATG16L1 CTNNB1 IFNG IL10 IL10RA
2 digestive/alimentary MP:0005381 10.35 SMAD4 TLR9 TNF ABCB1 ATG16L1 CTNNB1
3 cellular MP:0005384 10.32 MYO9B NOD2 SMAD4 TLR9 TNF ATG16L1
4 homeostasis/metabolism MP:0005376 10.3 ABCB1 ATG16L1 CTNNB1 IFNG IL10 IL10RA
5 growth/size/body region MP:0005378 10.28 IL2 IL23R MUC2 NOD2 SMAD4 TNF
6 immune system MP:0005387 10.28 IL1B IL2 IL23R MPO MUC2 MYO9B
7 cardiovascular system MP:0005385 10.26 ABCB1 ATG16L1 CTNNB1 IFNG IL10 IL1B
8 endocrine/exocrine gland MP:0005379 10.23 ATG16L1 CTNNB1 IFNG IL10 IL10RB IL17A
9 craniofacial MP:0005382 10.04 CTNNB1 IFNG IL10 IL17A IL1B SMAD4
10 mortality/aging MP:0010768 10.03 ABCB1 ATG16L1 CTNNB1 IFNG IL10 IL10RB
11 liver/biliary system MP:0005370 9.86 ABCB1 CTNNB1 IFNG IL10 IL10RB IL2
12 neoplasm MP:0002006 9.61 CTNNB1 IFNG IL10 IL1B IL2 IL23R
13 no phenotypic analysis MP:0003012 9.23 IL17A IL2 IL23R TNF ABCB1 CTNNB1

Drugs & Therapeutics for Colitis

Drugs for Colitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 389)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azathioprine Approved Phase 4,Phase 3,Phase 2 446-86-6 2265
2
Hydrocortisone Approved, Vet_approved Phase 4,Phase 1,Phase 2 50-23-7 657311 5754
3
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
6
Sucralfate Approved Phase 4 54182-58-0 0
7
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
8
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
9
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
10
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
11
Aminosalicylic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 65-49-6 4649
12
Vancomycin Approved Phase 4,Phase 3,Phase 2,Phase 1 1404-90-6 14969 441141
13
Loperamide Approved Phase 4,Phase 3,Phase 2 53179-11-6 3955
14
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2 22916-47-8 4189
15
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
16
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
17
Menthol Approved Phase 4,Phase 2 2216-51-5 16666
18
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 53-03-2 5865
19
Rifaximin Approved, Investigational Phase 4 80621-81-4 6436173
20
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
21
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
22
Cefazolin Approved Phase 4,Phase 2,Phase 3 25953-19-9 33255 656510
23
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
24
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
25
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1 443-48-1 4173
26
Nicotine Approved Phase 4 54-11-5 89594 942
27 Vedolizumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 943609-66-3
28
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 93-14-1 3516
29
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 73590-58-6 4594
30
Sulfamethoxazole Approved Phase 4 723-46-6 5329
31
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
32
Methotrexate Approved Phase 4,Phase 2 1959-05-2, 59-05-2 126941
33
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
34
Dextromethorphan Approved Phase 4 125-71-3 5362449 5360696
35
Losartan Approved Phase 4 114798-26-4 3961
36
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
37
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
38
Copper Approved, Investigational Phase 4 7440-50-8 27099
39
Zinc Approved, Investigational Phase 4 7440-66-6 32051 23994
40
Thioguanine Approved Phase 4 154-42-7 2723601
41
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
42
Nitrofurantoin Approved, Vet_approved Phase 4 67-20-9 5353830
43
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
44
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
45 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 1
46
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 1 59-30-3 6037
47
leucovorin Approved, Nutraceutical Phase 4,Phase 2 58-05-9 143 6006
48
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 54670067 5785
49
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 67-97-0 10883523 5280795 6221
50
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 50-14-6 5280793

Interventional clinical trials:

(show top 50) (show all 1075)

# Name Status NCT ID Phase Drugs
1 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
2 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
3 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
4 Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe Unknown status NCT01630096 Phase 4 Nu-Lytely
5 A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis Unknown status NCT02425852 Phase 4 Azathioprine;Infliximab;Prednisolone;Hydrocortisone
6 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
7 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
8 Confocal Endomicroscopy During Endoscopy Unknown status NCT00988273 Phase 4
9 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Unknown status NCT01632462 Phase 4 VSL#3
10 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
11 Manipulation of Visceral Sensitivity and Immune System in IBS Unknown status NCT00418340 Phase 4 probiotic (bacterial/dietary supplement)
12 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
13 Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab Unknown status NCT02453776 Phase 4 PRECISION dosing Infliximab
14 Pain Relief In Irritable Bowel Syndrome Unknown status NCT02573844 Phase 4 Proklama
15 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
16 Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) Completed NCT02092285 Phase 4 Golimumab
17 Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle Completed NCT01772615 Phase 4 Ciprofloxacin
18 Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis Completed NCT01408810 Phase 4 Infliximab
19 A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients Completed NCT00207688 Phase 4 Infliximab 5 mg/kg;Infliximab 10 mg/kg;Placebo
20 Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) Completed NCT02155335 Phase 4 Prefilled Syringe delivery of Golimumab;Smartject Device delivery of Golimumab
21 Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) Completed NCT00446849 Phase 4 MMX Mesalamine
22 Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis Completed NCT01201122 Phase 4 Mesalamine
23 Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis Completed NCT00542152 Phase 4 CYCLOSPORINE VS INFLIXIMAB
24 European Safety Registry in Ulcerative Colitis (Study P04808AM3) Completed NCT00705484 Phase 4 Standard Therapy
25 Asacol Dosing Study for Active Ulcerative Colitis Completed NCT00194818 Phase 4 Asacol (mesalamine)
26 Adacolumn in Refractory UC Patients Trial Completed NCT01481142 Phase 4
27 Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). Completed NCT02318667 Phase 4
28 Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis Completed NCT01124149 Phase 4 MMX mesalamine/ mesalazine
29 Dose Escalation and Remission (DEAR) Completed NCT00652145 Phase 4 mesalamine
30 Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) Completed NCT00219414 Phase 4
31 Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody Completed NCT00304408 Phase 4
32 Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis Completed NCT01418131 Phase 4 Rectal tacrolimus;Placebo
33 The NOR-SWITCH Study Completed NCT02148640 Phase 4 Innovator infliximab;Biosimilar infliximab
34 Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) Completed NCT01346826 Phase 4 Standard 2 hours-infusion;Accelerated 1 hour-infusion;Accelerated 30 minutes-infusion
35 Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate Completed NCT01991314 Phase 4 Ferrous sulphate
36 Low Volume Colon Preparation for IBD Completed NCT02248337 Phase 4 Colon preparation for colonoscopy
37 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease Completed NCT01908283 Phase 4
38 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Completed NCT02246361 Phase 4
39 Single-dose Linaclotide for Capsule Endoscopy Preparation Completed NCT02465385 Phase 4 Linaclotide
40 The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels Completed NCT00167882 Phase 4 5-aminosalicylate (Pentasa, Ferring)
41 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Completed NCT01341808 Phase 4
42 Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease Completed NCT01981889 Phase 4 Prednisone
43 Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea Completed NCT01670149 Phase 4 Rifaximin;Placebo
44 Efficacy Study of Pneumococcal Vaccination in Crohn's Disease Completed NCT01505855 Phase 4 23-valent polysaccharide pneumococcal vaccine
45 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Completed NCT01174186 Phase 4 Adalimumab
46 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
47 A Trial of Iron Replacement in Patients With Iron Deficiency. Completed NCT01067547 Phase 4 Iron Sucrose.;Iron sucrose
48 Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Completed NCT02162862 Phase 4 bupropion-SR
49 Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction Completed NCT01244698 Phase 4 Cefadroxil discontinued early;Cefadroxil until drain removal
50 Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis Recruiting NCT02345733 Phase 4 Antibiotic cocktail

Search NIH Clinical Center for Colitis

Cochrane evidence based reviews: colitis

Genetic Tests for Colitis

Genetic tests related to Colitis:

# Genetic test Affiliating Genes
1 Colitis 28

Anatomical Context for Colitis

The Foundational Model of Anatomy Ontology organs/tissues related to Colitis:

18
Colon

MalaCards organs/tissues related to Colitis:

38
Colon, T Cells, Neutrophil, Testes, Bone, Liver, Monocytes

Publications for Colitis

Articles related to Colitis:

(show top 50) (show all 4600)
# Title Authors Year
1
How Common-and How Serious- Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset. ( 29443839 )
2018
2
Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry. ( 29434945 )
2018
3
Introducing Traditional Herbal Medicine into Conventional Health Care in Treating Ulcerative Colitis: Primum Non Nocere. ( 29425926 )
2018
4
Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue. ( 29401083 )
2018
5
Regulation of JAK2/STAT3 and NF-I_B signal transduction pathways; Veronica polita alleviates dextran sulfate sodium-induced murine colitis. ( 29448206 )
2018
6
Fecal microbiota transplantation for severe complicated C. difficile colitis in a patient with acquired immunodeficiency syndrome. ( 29449093 )
2018
7
Ulcerative colitis followed by the development of typical intestinal BehAset disease: A case report. ( 29443756 )
2018
8
Ileal pouch of ulcerative colitis and familial adenomatous polyposis patients exhibit modulation of autophagy markers. ( 29422639 )
2018
9
Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn's Disease and Ulcerative Colitis. ( 29441064 )
2018
10
Genetic Variation and Gene Expression Levels of Tight Junction Genes Indicates Relationships Between PTEN as well as MAGI1 and Microscopic Colitis. ( 29204743 )
2018
11
Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis. ( 29422812 )
2018
12
Lymphocytic Colitis: Pathologic predictors of response to therapy. ( 29452215 )
2018
13
Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry. ( 29315163 )
2018
14
The possible relationship between Campylobacter spp./Arcobacter spp. and patients with ulcerative colitis. ( 29432367 )
2018
15
MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor I+-1. ( 29438285 )
2018
16
Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. ( 29370359 )
2018
17
Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. ( 29435325 )
2018
18
Cytomegalovirus Infection in Pediatric Severe Ulcerative Colitis-A Multicenter Study from the Pediatric Inflammatory Bowel Disease Porto Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. ( 29424814 )
2018
19
Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn's colitis. ( 29023984 )
2018
20
T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients. ( 29422814 )
2018
21
Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD<sup>+</sup>/SIRT1/SUV39H1/H3K9me3 signaling pathway. ( 29449535 )
2018
22
Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis. ( 29382152 )
2018
23
Duodenal amyloidosis secondary to ulcerative colitis. ( 29422811 )
2018
24
Histological features of ileitis differentiating pediatric Crohn disease from ulcerative colitis with backwash ileitis. ( 29089273 )
2018
25
Clozapine Associated With Microscopic Colitis in the Setting of Biopsy-Proven Celiac Disease. ( 29424803 )
2018
26
Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers? ( 29441549 )
2018
27
A case report of successful management of clostridium difficile colitis with antegrade Fidaxomicin through a mucous fistula obviating the need for subtotal colectomy. ( 29227855 )
2018
28
A case of pemphigus vulgaris associated with ulcerative colitis. ( 29422810 )
2018
29
Copaiba oil decreases oxidative stress and inflammation but not colon damage in rats with TNBS-induced colitis. ( 29446750 )
2018
30
Alterations in melatonin and serotonin signalling in the colonic mucosa of mice with dextran-sodium sulfate-induced colitis. ( 29447434 )
2018
31
Editor's Spotlight/Take 5: How Common-and How Serious-Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset. ( 29443838 )
2018
32
Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis. ( 29361101 )
2018
33
A data-based hypothesis explicating the observations that "Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study". ( 29447017 )
2018
34
Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. ( 29450747 )
2018
35
Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial. ( 29435324 )
2018
36
Eosinophilic colitis: Case series and literature review. ( 29103770 )
2018
37
Evaluation by MR Enterocolonography of Lansoprazole-induced Collagenous Colitis Accompanied with Protein-losing Enteropathy. ( 29033425 )
2018
38
Paediatric<i>Clostridium difficile</i>pseudomembranous colitis: a complication of refractory constipation? ( 29444797 )
2018
39
Editorial: infliximab trough levels and histological healing in ulcerative colitis-a step towards personalised biologic therapy. ( 29446129 )
2018
40
Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. ( 29441068 )
2018
41
Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis. ( 29427297 )
2018
42
Idiopathic Myointimal Hyperplasia of Mesenteric Veins: An Uncommon Cause of Ischemic Colitis With Distinct Mucosal Features. ( 28817406 )
2017
43
Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis. ( 28490634 )
2017
44
Identification of the distinguishing features of Crohn's disease and ischemic colitis using computed tomographic enterography. ( 28852526 )
2017
45
Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis. ( 28924114 )
2017
46
Functional variant in the promoter region of IL-27 alters gene transcription and confers a risk for ulcerative colitis in northern Chinese Han. ( 28069403 )
2017
47
Primary Colonic Eosinophilia and Eosinophilic Colitis in Adults. ( 27792062 )
2017
48
Ischemic Colitis Associated with Paclitaxel and Carboplatin Combination. ( 28878651 )
2017
49
Metachronous metastatic colonic small cell carcinoma and recurrent adenocarcinoma in a patient with ulcerative colitis. ( 29423143 )
2017
50
Acute Appendicitis: An Extracolonic Manifestation of Clostridium difficile Colitis. ( 28757875 )
2017

Variations for Colitis

Expression for Colitis

Search GEO for disease gene expression data for Colitis.

Pathways for Colitis

Pathways related to Colitis according to GeneCards Suite gene sharing:

(show top 50) (show all 69)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.08 CTNNB1 CXCL8 IFNG IL10 IL10RA IL10RB
2
Show member pathways
13.91 CTNNB1 CXCL8 IL10 IL10RA IL10RB IL17A
3
Show member pathways